Jaguar health, inc. (JAGX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14
Assets
Current assets:
Cash

1,215

3,495

2,069

1,606

2,571

2,568

726

2,411

7,808

520

220

2,760

1,205

950

1,813

3,875

7,214

7,697

10,377

12,379

746

845

Restricted cash

388

388

-

-

-

-

-

0

0

239

500

0

21

511

988

-

-

-

-

-

-

-

Accounts receivable

1,083

1,692

1,593

2,097

914

995

1,028

583

362

467

759

12

-

4

4

19

12

55

8

29

8

-

Other receivable

4

2

-

92

2

6

176

70

2

1

17

197

-

-

-

-

-

-

-

-

-

-

Due from former parent

-

-

-

-

-

-

-

-

-

-

-

222

221

299

273

-

2

3

4

5

-

-

Inventory

2,704

2,129

2,322

2,393

2,960

3,342

2,550

2,844

2,328

2,072

1,831

396

392

412

276

276

269

229

256

306

314

198

Operating lease - right-of-use asset

372

553

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

335

-

-

1,255

-

-

-

303

10

65

72

67

-

-

143

-

-

2,738

2,480

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

360

387

-

-

850

625

324

353

149

122

24

Prepaid expenses and other current assets

1,074

1,263

1,563

822

866

1,237

1,765

966

365

497

609

-

-

302

655

-

-

-

-

-

-

-

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

-

Deferred finance charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

102

-

37

-

Total current assets

6,840

9,522

7,548

7,348

7,315

8,149

7,502

6,876

10,867

3,799

4,242

3,960

2,581

2,555

4,078

5,021

8,124

8,453

11,102

12,869

3,977

3,547

Property and equipment, net

707

710

720

737

745

760

775

1,198

1,213

1,222

840

855

870

885

900

916

907

829

834

866

866

872

Operating lease - right-of-use asset

-

-

730

905

1,077

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

5,210

5,210

5,210

5,210

18,389

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

25,602

26,024

26,445

26,867

31,288

31,710

32,132

32,553

32,975

33,397

36,118

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,144

2,821

3,000

4,500

-

-

-

Deferred finance charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

82

-

-

-

Other assets

127

154

181

208

235

420

501

317

-

-

396

122

122

122

122

122

122

122

122

122

-

-

Total assets

33,276

36,410

35,626

36,066

40,662

41,041

46,122

46,156

50,267

43,629

59,988

4,938

3,574

3,563

5,101

7,203

11,975

12,405

16,641

13,857

4,843

4,419

Liabilities, convertible preferred stock and stockholders' equity
Current liabilities:
Accounts payable

5,597

5,352

4,752

6,390

6,563

5,414

6,450

5,000

3,162

7,354

7,857

3,443

1,465

517

443

413

559

574

276

349

1,764

698

Loan advance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

-

License fee payable to former parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

425

950

1,450

1,600

-

Due to former parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

Due to parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

-

Deferred revenue

-

-

-

-

-

-

-

0

-

-

224

184

208

224

246

262

279

251

336

373

388

23

Deferred collaboration revenue

-

-

-

-

-

-

-

-

0

177

814

1,451

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

3

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

3,309

2,922

3,364

5,273

3,980

4,939

4,050

2,636

1,664

2,204

1,927

860

1,266

582

410

653

583

798

648

448

1,754

1,317

Notes Payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

913

392

Warrant liability

2

3

10

5,182

1,275

220

48

74

192

103

163

551

1,252

799

-

-

-

0

-

-

977

601

Operating lease liability

228

337

442

425

521

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

-

-

-

-

-

8

15

11

19

20

-

-

-

-

-

-

-

-

-

-

Conversion option liability

-

-

-

-

-

-

-

0

0

111

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

5

-

-

-

-

-

-

-

-

-

-

-

Convertible debt, net of discount

-

-

-

-

11,149

11,239

1,055

660

690

2,672

3,213

1,777

150

150

150

150

150

150

150

123

786

424

Notes payable, net of discount

7,132

6,778

-

3,563

-

4,845

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, net of discount

-

-

-

-

1,258

-

4,531

3,990

3,656

1,141

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt

-

-

-

-

-

-

0

0

0

1,609

1,801

2,071

1,994

1,919

1,846

1,465

2,119

1,707

1,454

-

-

-

Total current liabilities

16,268

15,392

8,568

20,835

24,750

26,658

16,136

12,369

9,384

15,385

16,026

10,362

8,425

4,192

3,096

2,945

3,692

3,907

3,815

2,744

9,206

3,475

Notes payable long term

400

450

6,678

7,759

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability - long-term

-

-

-

116

116

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible long-term debt, net of discount

-

-

-

-

-

-

-

10,768

10,875

-

-

835

1,332

1,817

2,271

2,685

3,629

4,095

4,457

-

-

-

Convertible debt non-current, net of discount

-

-

-

-

-

-

10,661

-

-

10,982

11,161

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

990

-

-

-

-

-

-

-

-

-

-

-

License fee payable to former parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,875

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

7

7

6

6

6

4

3

1

-

-

-

Total liabilities

16,668

15,842

15,246

28,710

24,866

26,658

26,797

23,137

20,259

26,368

28,177

11,205

9,765

6,017

5,374

5,638

7,326

8,006

8,275

2,744

9,206

5,350

Commitments and contingencies (See Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

Series A redeemable convertible preferred stock: $0.0001 par value, 5,524,926 shares authorized at March 31, 2020 and December 31, 2019; 5,524,926 shares issued and outstanding at March 31, 2020 and December 31, 2019; (redemption amount of $12,738,822 at March 31, 2020 and December 31, 2019; liquidation preference of $9,199,002 at March 31, 2020 and December 31, 2019)

-

-

9,000

9,000

9,000

-

9,000

9,000

9,000

-

-

-

-

-

-

-

-

-

-

-

7,492

-

Stockholders' equity:
Preferred stock value

-

-

409

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock: $0.0001 par value, 10,000,000 shares authorized at September 30, 2017 and December 31, 2016; no shares issued and outstanding at September 30, 2017 and December 31, 2016.

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

0

-

-

-

0

Common stock value

-

-

-

-

-

-

-

-

-

-

-

1

1

-

1

1

1

0

0

0

0

0

Additional paid-in capital

145,861

142,046

138,096

117,927

109,640

99,929

92,216

89,771

89,092

79,661

74,000

40,688

38,959

37,980

36,485

34,908

34,334

30,100

29,936

29,723

1,493

1,175

Accumulated deficit

-141,000

-133,090

-127,130

-119,575

-102,900

-94,550

-81,896

-75,758

-68,101

-62,404

-42,197

-46,957

-45,151

-40,436

-36,759

-33,344

-29,686

-25,702

-21,571

-18,610

-13,348

-9,410

Total stockholders' equity

6,233

10,673

11,379

-1,644

6,795

5,383

10,324

14,018

21,007

17,261

31,810

-6,266

-6,190

-2,454

-273

1,565

4,648

4,399

8,365

11,113

-11,854

-8,235

Total liabilities, convertible preferred stock and stockholders' equity

33,276

36,410

35,626

36,066

40,662

41,041

46,122

46,156

50,267

43,629

59,988

4,938

3,574

3,563

5,101

7,203

11,975

12,405

16,641

13,857

4,843

4,419

Series A
Series A redeemable convertible preferred stock: $0.0001 par value, 5,524,926 shares authorized at March 31, 2020 and December 31, 2019; 5,524,926 shares issued and outstanding at March 31, 2020 and December 31, 2019; (redemption amount of $12,738,822 at March 31, 2020 and December 31, 2019; liquidation preference of $9,199,002 at March 31, 2020 and December 31, 2019)

10,375

9,895

-

-

-

9,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B convertible preferred stock
Series A redeemable convertible preferred stock: $0.0001 par value, 5,524,926 shares authorized at March 31, 2020 and December 31, 2019; 5,524,926 shares issued and outstanding at March 31, 2020 and December 31, 2019; (redemption amount of $12,738,822 at March 31, 2020 and December 31, 2019; liquidation preference of $9,199,002 at March 31, 2020 and December 31, 2019)

476

476

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock value

476

476

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B-2 convertible preferred stock
Series A redeemable convertible preferred stock: $0.0001 par value, 5,524,926 shares authorized at March 31, 2020 and December 31, 2019; 5,524,926 shares issued and outstanding at March 31, 2020 and December 31, 2019; (redemption amount of $12,738,822 at March 31, 2020 and December 31, 2019; liquidation preference of $9,199,002 at March 31, 2020 and December 31, 2019)

916

1,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock value

916

1,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock - voting
Series A redeemable convertible preferred stock: $0.0001 par value, 5,524,926 shares authorized at December 31, 2019 and December 31, 2018; 5,524,926 shares issued and outstanding at December 31, 2019 and December 31, 2018; (redemption amount of $12,738,822 andzero at December 31, 2019 and December 31, 2018, respectively)

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock value

2

1

0

0

5

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock - non-voting
Series A redeemable convertible preferred stock: $0.0001 par value, 5,524,926 shares authorized at December 31, 2019 and December 31, 2018; 5,524,926 shares issued and outstanding at December 31, 2019 and December 31, 2018; (redemption amount of $12,738,822 andzero at December 31, 2019 and December 31, 2018, respectively)

-

-

-

-

-

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock value

4

4

4

4

4

4

-

-

-

4

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

-

-

-

-

-

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-